glp-1 biosimilar supplements are everywhere—but do they actually work? As demand for weight-loss drugs grows, companies are cashing in on products that claim to support GLP-1 goals, often with little oversight. Tap the Trends to watch: GLP-1 drugs,

When evaluating patient reports of nightmares during Wegovy treatment, clinicians must consider alternative explanations

5,6 In addition, receptor activator of nuclear factor kappa beta ligand (RANKL), that plays a crucial role in osteoclast activity and bone resorption, 21 also directly influences pancreatic beta-cell function and overall metabolism, with its activity being compromised in obesity and T2D

The mechanism behind a transdermal wellness patch is straightforward yet effective

This marks the second round of enforcement action since the agency's September crackdown on misleading pharmaceutical ads

The report analyses the Global Glucagon-Like Peptide 1 (GLP-1) Agonist market by Distribution Channel (Clinics, Ambulatory Surgical Centers, and Hospitals)